Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping

BACKGROUND: The chemotherapeutic agent 5-fluorouracil (5-FU) is catabolized by dihydropyrimidine dehydrogenase (DPD), the deficiency of which may lead to severe toxicity or death. Since 2019, DPD deficiency testing, based on uracilemia, is mandatory in France and recommended in Europe before initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Royer, B., Launay, M., Ciccolini, J., Derain, L., Parant, F., Thomas, F., Guitton, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265596/
https://www.ncbi.nlm.nih.gov/pubmed/37267808
http://dx.doi.org/10.1016/j.esmoop.2023.101577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265596/
https://www.ncbi.nlm.nih.gov/pubmed/37267808
http://dx.doi.org/10.1016/j.esmoop.2023.101577

Ejemplares similares